171 related articles for article (PubMed ID: 30032169)
1. Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
Zhang K; Ma M; Dong C; Hashimoto K
Int J Neuropsychopharmacol; 2018 Nov; 21(11):1025-1030. PubMed ID: 30032169
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model.
Xiong Z; Fujita Y; Zhang K; Pu Y; Chang L; Ma M; Chen J; Hashimoto K
Behav Brain Res; 2019 Aug; 368():111904. PubMed ID: 30980851
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.
Yang C; Ren Q; Qu Y; Zhang JC; Ma M; Dong C; Hashimoto K
Biol Psychiatry; 2018 Jan; 83(1):18-28. PubMed ID: 28651788
[TBL] [Abstract][Full Text] [Related]
4. Lack of Antidepressant Effects of Low-Voltage-Sensitive T-Type Calcium Channel Blocker Ethosuximide in a Chronic Social Defeat Stress Model: Comparison with (R)-Ketamine.
Tian Z; Dong C; Zhang K; Chang L; Hashimoto K
Int J Neuropsychopharmacol; 2018 Nov; 21(11):1031-1036. PubMed ID: 30085247
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
Zhang K; Dong C; Fujita Y; Fujita A; Hashimoto K
Int J Neuropsychopharmacol; 2018 Feb; 21(2):157-163. PubMed ID: 29155989
[TBL] [Abstract][Full Text] [Related]
6. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
[TBL] [Abstract][Full Text] [Related]
7. Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model.
Yang C; Qu Y; Fujita Y; Ren Q; Ma M; Dong C; Hashimoto K
Transl Psychiatry; 2017 Dec; 7(12):1294. PubMed ID: 29249803
[TBL] [Abstract][Full Text] [Related]
8. Lack of dopamine D
Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Shirayama Y; Hashimoto K
Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):271-275. PubMed ID: 30927075
[TBL] [Abstract][Full Text] [Related]
9. Vicarious Social Defeat Stress Induces Depression-Related Outcomes in Female Mice.
Iñiguez SD; Flores-Ramirez FJ; Riggs LM; Alipio JB; Garcia-Carachure I; Hernandez MA; Sanchez DO; Lobo MK; Serrano PA; Braren SH; Castillo SA
Biol Psychiatry; 2018 Jan; 83(1):9-17. PubMed ID: 28888327
[TBL] [Abstract][Full Text] [Related]
10. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.
Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K
Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress.
Zhang J; Fujita Y; Chang L; Pu Y; Qu Y; Wang S; Hashimoto K
Behav Brain Res; 2020 Feb; 379():112397. PubMed ID: 31790783
[TBL] [Abstract][Full Text] [Related]
12. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.
Zhang K; Fujita Y; Hashimoto K
Sci Rep; 2018 Mar; 8(1):4007. PubMed ID: 29507385
[TBL] [Abstract][Full Text] [Related]
13. (R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine.
Yang C; Qu Y; Abe M; Nozawa D; Chaki S; Hashimoto K
Biol Psychiatry; 2017 Sep; 82(5):e43-e44. PubMed ID: 28104224
[No Abstract] [Full Text] [Related]
14. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Ren Q; Dong C; Fujita Y; Hashimoto K
Pharmacol Biochem Behav; 2019 Jun; 181():53-59. PubMed ID: 31034852
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling.
Wei Y; Chang L; Hashimoto K
Eur Neuropsychopharmacol; 2021 Sep; 50():55-63. PubMed ID: 33971385
[TBL] [Abstract][Full Text] [Related]
17. Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABA
Xiong Z; Zhang K; Ishima T; Ren Q; Chang L; Chen J; Hashimoto K
Pharmacol Biochem Behav; 2018 Dec; 175():139-145. PubMed ID: 30359627
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant Potential of (
Fukumoto K; Toki H; Iijima M; Hashihayata T; Yamaguchi JI; Hashimoto K; Chaki S
J Pharmacol Exp Ther; 2017 Apr; 361(1):9-16. PubMed ID: 28115553
[TBL] [Abstract][Full Text] [Related]
19. Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model.
Qu Y; Yang C; Ren Q; Ma M; Dong C; Hashimoto K
Sci Rep; 2017 Nov; 7(1):15725. PubMed ID: 29147024
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
